CoreStrength

CoreStrength is a biotechnology company dedicated to developing transformative therapies for muscle health, with a primary focus on sarcopenia and muscle loss associated with GLP-1 weight loss treatments. The company was founded by a team of industry veterans, including former leaders from Novartis and Biogen who possess extensive expertise in musculoskeletal diseases and translational medicine. CoreStrength aims to address the critical need for maintaining muscle mass and physical function in aging populations and patients undergoing intensive weight loss. By targeting novel biological pathways, the company is building a pipeline of candidates designed to preserve strength and improve overall quality of life. Their mission is to redefine muscle health as a central pillar of healthy aging and metabolic wellness.